ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Clinical trials for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROTIC CARDIOVASCULAR DISEASE trials appear
Sign up with your email to follow new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can extremely low cholesterol save more hearts? new trial aims to find out
Disease control Not yet recruitingThis study compares two cholesterol-lowering strategies in 6,000 Chinese patients with very high-risk heart disease. One group aims for ultra-low LDL cholesterol below 1.0 mmol/L, while the other targets a moderate level of 1.0-1.39 mmol/L. Researchers will track heart attacks, s…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
3,000 volunteers to reveal hidden heart risks in qatar
Knowledge-focused Not yet recruitingThis study follows 3,000 adults in Qatar—both citizens and long-term residents—to track how cardiometabolic conditions like diabetes and heart disease develop over time. Participants are grouped by blood sugar status (normal, pre-diabetes, or diabetes) and monitored for major car…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Sponsor: Weill Cornell Medical College in Qatar • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Childhood cancer Survivors' hearts under the microscope
Knowledge-focused Not yet recruitingThis study will use heart scans and blood tests to check for early signs of heart disease in 650 adult survivors of childhood cancer. The goal is to better understand who is at highest risk due to past cancer treatments like radiation or chemotherapy. Results will be compared to …
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Italian study to track Real-World use of Next-Gen cholesterol drugs
Knowledge-focused Not yet recruitingThis study will look at how consistently nearly 6,000 adults in Italy take three newer cholesterol-lowering drugs (inclisiran, evolocumab, and alirocumab) over the long term. Researchers will analyze prescription records to measure adherence and persistence in everyday medical pr…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC